These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2032389)

  • 1. Evidence for a role for the cardiovascular amplifiers in human primary hypertension.
    Jennings G; Korner PI; Sudhir K; Esler M; Angus JA; Laufer E
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):37-41. PubMed ID: 2032389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension.
    Korner PI; Bobik A; Jennings GL; Angus JA; Anderson WP
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S25-32. PubMed ID: 1715480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular structural alterations in hypertension: effect of treatment.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Clin Exp Hypertens; 1996; 18(3-4):513-22. PubMed ID: 8743039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of cardiovascular structural changes during long-term antihypertensive therapy.
    Agabiti-Rosei E; Muiesan ML
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():41-7. PubMed ID: 1834845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplifier function of resistance vessels and the left ventricle in hypertension.
    Korner PI; Angus JA; Bobik A; Jennings GL
    J Hypertens Suppl; 1991 Dec; 9(2):S31-40; discussion S40-1. PubMed ID: 1838766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are cardiac and vascular "amplifiers" both necessary for the development of hypertension?
    Korner PI; Bobik A; Angus JJ
    Kidney Int Suppl; 1992 Jun; 37():S38-44. PubMed ID: 1385838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes.
    Korner PI; Jennings GL; Esler MD; Anderson WP; Bobik A; Adams M; Angus JA
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1730-8. PubMed ID: 2961426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of cardiovascular structural changes--a preventive strategy.
    Dahlöf B
    Clin Exp Hypertens A; 1990; 12(5):877-96. PubMed ID: 2145096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive therapy on the cardiovascular amplifiers.
    Korner PI; Adams MA; Jennings GL; Bobik A
    Clin Exp Pharmacol Physiol; 1988 Mar; 15(3):191-7. PubMed ID: 2978739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive treatment on small artery remodelling.
    Agabiti-Rosei E; Heagerty AM; Rizzoni D
    J Hypertens; 2009 Jun; 27(6):1107-14. PubMed ID: 19293726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B
    Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of antihypertensive therapy: prevalence of relapses and predictors of successful withdrawal in a hypertensive community.
    Schmieder RE; Rockstroh JK; Gatzka CD; Rüddel H; Schächinger H
    Cardiology; 1997; 88(3):277-84. PubMed ID: 9129850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
    Korner PI; Jennings GL; Esler MD; Broughton A
    J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment.
    Agabiti-Rosei E; Muiesan ML; Geri A; Romanelli G; Montani G; Muiesan G
    Am J Med; 1988 Mar; 84(3A):125-8. PubMed ID: 2975461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ; Kanellakis P; Bobik A
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How hypertension redevelops after cessation of long-term therapy.
    Jennings GL; Korner PI; Laufer E; Esler MD; Burton D; Bruce A
    J Hypertens Suppl; 1984 Dec; 2(3):S217-9. PubMed ID: 6599672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular hypertrophy and hypertension: causes and consequences.
    Korner PI
    Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.
    Alpert MA; Omran J; Bostick BP
    Curr Obes Rep; 2016 Dec; 5(4):424-434. PubMed ID: 27744513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.